Viewing StudyNCT00083759



Ignite Creation Date: 2024-05-05 @ 11:35 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00083759
Status: TERMINATED
Last Update Posted: 2016-07-18
First Post: 2004-06-01

Brief Title: Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate
Sponsor: Biogen
Organization: Biogen

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-05
Start Date Type: None
Primary Completion Date: 2005-02
Primary Completion Date Type: ACTUAL
Completion Date: None
Completion Date Type: None
First Submit Date: 2004-06-01
First Submit QC Date: June 2 2004
Study First Post Date: 2004-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2009-06-02
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-07-14
Last Update Post Date: 2016-07-18
Last Update Post Date Type: ESTIMATED